Margherita Bracchi

1.7k total citations
25 papers, 268 citations indexed

About

Margherita Bracchi is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Margherita Bracchi has authored 25 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 10 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Margherita Bracchi's work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (6 papers). Margherita Bracchi is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (6 papers). Margherita Bracchi collaborates with scholars based in United Kingdom, Italy and Denmark. Margherita Bracchi's co-authors include Anton Pozniak, Giovanni Di Perri, Andrea Calcagno, Stefano Bonora, Antonio D’Avolio, Marco Simiele, Christoph Boesecke, Patrick Mallon, Manuel Battegay and Andri Rauch and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Margherita Bracchi

19 papers receiving 267 citations

Peers

Margherita Bracchi
Tanakorn Apornpong Thailand
Eugénio Teófilo Portugal
Fabienne Caby France
Maddalena Cerrone United Kingdom
Stephan Klauke Germany
Veronique Obry‐Roguet France
JM Miró Spain
Win Min Han Thailand
Elena Álvarez Spain
Olivier Ségéral France
Tanakorn Apornpong Thailand
Margherita Bracchi
Citations per year, relative to Margherita Bracchi Margherita Bracchi (= 1×) peers Tanakorn Apornpong

Countries citing papers authored by Margherita Bracchi

Since Specialization
Citations

This map shows the geographic impact of Margherita Bracchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margherita Bracchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margherita Bracchi more than expected).

Fields of papers citing papers by Margherita Bracchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margherita Bracchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margherita Bracchi. The network helps show where Margherita Bracchi may publish in the future.

Co-authorship network of co-authors of Margherita Bracchi

This figure shows the co-authorship network connecting the top 25 collaborators of Margherita Bracchi. A scholar is included among the top collaborators of Margherita Bracchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margherita Bracchi. Margherita Bracchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leone, Alberto Giovanni, Mark P. Lythgoe, Jeremy L. Warner, et al.. (2025). Inclusion of people living with HIV in Food and Drug Administration (FDA) oncology pivotal registration trials from 2020 to 2024.. Journal of Clinical Oncology. 43(16_suppl). 1517–1517.
2.
Sweni, Shah, Alessia Dalla Pria, Borja Mora‐Peris, et al.. (2025). Dolutegravir with enteral feeds in intensive care: Case series with therapeutic drug monitoring. British Journal of Clinical Pharmacology. 91(11). 3272–3278.
3.
Bracchi, Margherita, et al.. (2024). A case report highlighting drug–drug interactions between 3 life‐saving treatments: Feminizing hormones, antiretrovirals and antituberculosis drugs. British Journal of Clinical Pharmacology. 90(10). 2383–2386.
4.
5.
Bracchi, Margherita, et al.. (2023). Calvarial disease in secondary syphilis presenting as headache. Practical Neurology. 24(1). 76–77. 1 indexed citations
6.
Falconer, Jonathan, et al.. (2023). Mycobacterial disease causing chylous effusions in two patients living with uncontrolled HIV. BMJ Case Reports. 16(7). e252000–e252000.
7.
Bracchi, Margherita, et al.. (2023). Direct switch from an efavirenz-based regimen to intramuscular long-acting cabotegravir plus rilpivirine: A case report. International Journal of STD & AIDS. 35(4). 311–313. 2 indexed citations
8.
Bracchi, Margherita, Nicole Pagani, Alessia Dalla Pria, et al.. (2021). A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients.. PubMed. 22(5). 128–139.
9.
Bracchi, Margherita, et al.. (2021). Nannizziopsis Immune Reconstitution Inflammatory Syndrome in a Patient with HIV: First Reported Case. SHILAP Revista de lepidopterología. 8(11). 3021–3021. 1 indexed citations
10.
Rokx, Casper, Henrieke Prins, Linos Vandekerckhove, et al.. (2021). Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium. Journal of Virus Eradication. 7(2). 100045–100045. 2 indexed citations
11.
12.
Bracchi, Margherita, et al.. (2021). A case of pulmonary nodules in a patient living with HIV diagnosed with secondary syphilis. BMJ Case Reports. 14(8). e243765–e243765. 4 indexed citations
13.
Vera, Jaime H., Margherita Bracchi, Jasmini Alagaratnam, et al.. (2019). Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART. Brain Sciences. 9(8). 195–195. 14 indexed citations
14.
Cerrone, Maddalena, Margherita Bracchi, Sean Wasserman, et al.. (2019). Safety implications of combined antiretroviral and anti-tuberculosis drugs. Expert Opinion on Drug Safety. 19(1). 23–41. 28 indexed citations
15.
Ryom, Lene, Christoph Boesecke, Margherita Bracchi, et al.. (2018). Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0. HIV Medicine. 19(5). 309–315. 100 indexed citations
16.
Dickinson, Laura, Margherita Bracchi, Laura Else, et al.. (2016). Population pharmacokinetics (PK) of dolutegravir (DTG) alone and following treatment switch. 1 indexed citations
17.
Bonora, Stefano, Stefano Rusconi, Andrea Calcagno, et al.. (2015). Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). Journal of Antimicrobial Chemotherapy. 70(11). 3096–3099. 13 indexed citations
18.
Calcagno, Andrea, Marco Simiele, Margherita Bracchi, et al.. (2014). Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-Infected Patients Are Associated With Compartmental Viral Control. Clinical Infectious Diseases. 60(2). 311–317. 45 indexed citations
19.
Calcagno, Andrea, Jessica Cusato, Marco Simiele, et al.. (2013). High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis. Journal of Antimicrobial Chemotherapy. 69(1). 241–245. 29 indexed citations
20.
Masera, Giuseppe, et al.. (1980). Cerebral aspergillosis in a child with acute lymphoblastic leukemia. A case report.. PubMed. 65(6). 773–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanakorn Apornpong Breakdown of academic impact, for papers by Eugénio Teófilo Breakdown of academic impact, for papers by Fabienne Caby Breakdown of academic impact, for papers by Maddalena Cerrone Breakdown of academic impact, for papers by Stephan Klauke Breakdown of academic impact, for papers by Veronique Obry‐Roguet Breakdown of academic impact, for papers by JM Miró Breakdown of academic impact, for papers by Win Min Han Breakdown of academic impact, for papers by Elena Álvarez Breakdown of academic impact, for papers by Olivier Ségéral
Rankless by CCL
2026